$100.57
0.15%
NYSE, Nov 19, 03:59 pm EST. Closed.
ISIN
IE00BTN1Y115
Symbol
MDT

Medtronic Stock price

$100.61
+7.84 8.45% 1M
+22.03 28.04% 6M
+4.55 4.74% YTD
+0.27 0.27% 1Y
+25.45 33.86% 3Y
-16.61 14.17% 5Y
+20.03 24.86% 10Y
+51.66 105.54% 20Y
NYSE, Closing price Thu, Nov 19 2026
-0.11 0.11%

AI Insights on Medtronic Insights AI Insights on Medtronic

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?
How is the company managed?

Is Medtronic a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,085 stocks worldwide.

Key metrics

Basic
Market capitalization
$128.8b
Enterprise Value
$148.2b
Net debt
$19.3b
Cash
$8.8b
Shares outstanding
1.3b
Valuation
P/E
24.7
P/S | estimate
3.4 | 3.3
EV/Sales | estimate
4.0 | 3.8
EV/FCF | ex SBC
24.2 | 26.3
P/B
2.6
Dividends
DPS
$2.84
Yield 1Y | 5Y
2.8% | 2.9%
Growth 1Y | 5Y
1.4% | 4.1%
Payout 1Y | 3Y
76.1% | 83.2%
Increased
25 Years
Financials
Revenue | estimate
$37.5b | $39.5b
EBITDA
$9.2b
EBIT
$7.5b
Net Income
$5.2b
Free Cash Flow | ex SBC
$6.1b | $5.6b
Growth
Revenue | estimate
9.8% | 8.5%
EBITDA
7.7%
EBIT
11.8%
Net Income
12.3%
Free Cash Flow
15.7%
Margin
Gross
65.7%
EBITDA
24.5%
EBIT
19.9%
Net
13.9%
Free Cash Flow | ex SBC
16.3% | 15.0%
Financial Health
Equity Ratio
53.2%
Return on Equity
9.7%
ROCE
9.2%
ROIC
7.4%
Debt/Equity
0.6
Share-Based Compensation & Dilution
SBC | % of Revenue
$496.0m | 1.3%
SBC as % of FCF
8.1%
SBC Growth 1Y
14.8%
Share Count Growth 1Y
-0.1%
Shareholder Yield
3.0%
More
EPS
$4.1
FCF per Share
$4.8
Short interest
1.8%
Employees
95k
Rev per Employee
$380.0k

Medtronic Stock Analysis

Unlock Scores for Free

Analyst Opinions

35 Analysts have issued a Medtronic forecast:

23x Buy
66%
12x Hold
34%

Analyst Opinions

35 Analysts have issued a Medtronic forecast:

Buy
66%
Hold
34%

Medtronic Events

Upcoming Event
NOV
24
Q2 2027 Earnings Call
in 5 days
View Past Earnings Reaction
Past Events
NOV
12
Special Call - Medtronic plc
7 days ago
SEP
15
Morgan Stanley 24th Annual Global Healthcare Conference
2 months ago
SEP
8
Wells Fargo 21st Annual Healthcare Conference
2 months ago
SEP
1
Q1 2027 Earnings Call
3 months ago
JUN
3
Q4 2026 Earnings Call
6 months ago
MAR
11
Leerink Global Healthcare Conference 2026
8 months ago
MAR
10
Barclays 28th Annual Global Healthcare Conference
8 months ago
FEB
17
Q3 2026 Earnings Call
9 months ago
JAN
12
44th Annual J.P. Morgan Healthcare Conference
10 months ago
NOV
18
Q2 2026 Earnings Call
about one year ago

Financial data from Medtronic

Jul '26
+/-
%
37,541 37,541
10% 10%
100%
- Direct Costs 12,862 12,862
9% 9%
34%
24,679 24,679
10% 10%
66%
- Selling and Administrative Expenses 12,131 12,131
10% 10%
32%
- Research and Development Expense 2,918 2,918
5% 5%
8%
9,206 9,206
8% 8%
25%
- Depreciation and Amortization 1,724 1,724
7% 7%
5%
EBIT (Operating Income) EBIT 7,482 7,482
12% 12%
20%
Net Profit 5,231 5,231
12% 12%
14%

In millions USD.

Don't miss a Thing! We will send you all news about Medtronic directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Medtronic Stock News

Neutral
PRNewsWire
●
3 days ago
An expanded U.S. 510(k) extends the Hugo™ RAS system's reach into one of the fastest-growing areas of U.S. robotic surgery.  GALWAY, Ireland, Nov. 17, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the U.S. Food and Drug Administration (FDA) has cleared the Hugo™ robotic-assisted surgery (RAS) system for use in general surgery procedures.
Neutral
PRNewsWire
●
4 days ago
GALWAY, Ireland, Nov. 16, 2026 /PRNewswire/ -- Medtronic (NYSE: MDT), the global leader in healthcare technology, today announced its intent to acquire Contego Medical, a privately held medical device company focused on innovative solutions for carotid artery disease and peripheral thrombectomy. The acquisition will build on the company's successful, exclusive U.S. distribution agreement with C...
Neutral
Market Watch
●
6 days ago
There are a variety of ways to select dividend stocks. John Buckingham, a veteran value-oriented stock picker, believes the best approach is to focus on a stock's total return potential, which means emphasizing long-term growth first, and income second.
More Medtronic News

Company Profile

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiac and Vascular Group; Minimally Invasive Technologies Group; Restorative Therapies Group; and Diabetes Group. The Cardiac and Vascular Group segment consist Cardiac Rhythm and Heart Failure, Coronary and Structural Heart, and Aortic and Peripheral Vascular divisions. The Minimally Invasive Technologies Group segment comprises Surgical Innovations and Respiratory, Gastrointestinal, and Renal divisions. The Restorative Therapies Group contains Spine, Brain, Specialty Therapies, and Pain Therapies divisions. The Diabetes Group segment focuses in the development, manufacturing, and marketing of products and services for the management of Type I and Type II diabetes. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Head office United States
CEO Mr. Martha
Employees 95,000
Founded 2014
Website www.medtronic.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today